We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$585M
AUM Growth
+$25.3M
Cap. Flow
-$29M
Cap. Flow %
-4.96%
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$3.6M
2
NVDA icon
NVIDIA
NVDA
+$1.81M
3
NTRA icon
Natera
NTRA
+$1.51M
4
PFE icon
Pfizer
PFE
+$1.41M
5
S icon
SentinelOne
S
+$706K

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.86M
2
MSFT icon
Microsoft
MSFT
+$2.82M
3
MA icon
Mastercard
MA
+$2.78M
4
CMCSA icon
Comcast
CMCSA
+$2.56M
5
AAPL icon
Apple
AAPL
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 35%
2 Healthcare 14.27%
3 Consumer Discretionary 13.55%
4 Communication Services 11.79%
5 Financials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARES icon
126
Ares Management
ARES
$28.9B
$408K 0.07%
5,022
-2,601
-34% -$212K
PHR icon
127
Phreesia
PHR
$663M
$400K 0.07%
9,613
-618
-6% -$36.7K
KLAC icon
128
KLA
KLAC
$239B
$397K 0.07%
9,240
TENB icon
129
Tenable Holdings
TENB
$3.6B
$395K 0.07%
7,164
-460
-6% -$23.8K
CUBI icon
130
Customers Bancorp
CUBI
$2.66B
$394K 0.07%
6,031
AVGO icon
131
Broadcom
AVGO
$1.85T
$377K 0.06%
5,670
GSHD icon
132
Goosehead Insurance
GSHD
$2.2B
$372K 0.06%
2,858
-183
-6% -$26.3K
AZTA icon
133
Azenta
AZTA
$1.3B
$365K 0.06%
3,544
-1,555
-30% -$169K
SRPT icon
134
Sarepta Therapeutics
SRPT
$1.57B
$363K 0.06%
4,028
-259
-6% -$22.1K
VRNS icon
135
Varonis Systems
VRNS
$4.59B
$349K 0.06%
7,154
-460
-6% -$26.2K
LSCC icon
136
Lattice Semiconductor
LSCC
$17.6B
$339K 0.06%
4,400
+2,040
+86% +$151K
MSA icon
137
Mine Safety
MSA
$7.35B
$336K 0.06%
2,224
-142
-6% -$21.3K
LAD icon
138
Lithia Motors
LAD
$8.47B
$333K 0.06%
1,121
-72
-6% -$22.2K
RH icon
139
RH
RH
$3.13B
$333K 0.06%
621
-39
-6% -$24K
EPRT icon
140
Essential Properties Realty Trust
EPRT
$6.77B
$322K 0.06%
11,069
-6,924
-38% -$198K
RLI icon
141
RLI Corp
RLI
$5.62B
$320K 0.05%
5,712
-1,956
-26% -$106K
RRX icon
142
Regal Rexnord
RRX
$13.7B
$313K 0.05%
1,835
-118
-6% -$18.7K
BILL icon
143
BILL Holdings
BILL
$4.49B
$310K 0.05%
1,245
PM icon
144
Philip Morris
PM
$297B
$309K 0.05%
3,212
KO icon
145
Coca-Cola
KO
$377B
$308K 0.05%
5,209
PEN icon
146
Penumbra
PEN
$12.7B
$308K 0.05%
1,072
-68
-6% -$18K
ADI icon
147
Analog Devices
ADI
$179B
$307K 0.05%
1,746
CVX icon
148
Chevron
CVX
$392B
$307K 0.05%
2,615
AGYS icon
149
Agilysys
AGYS
$2.97B
$302K 0.05%
6,790
-436
-6% -$20.7K
BL icon
150
BlackLine
BL
$1.84B
$292K 0.05%
2,820

Similar funds

Silvant Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.

  • Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
  • Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
  • Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
  • Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
  • Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
  • Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
  • Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.

Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.